ELGX Endologix Inc.
2,287
$0.0779
$0.0043
(5.84%)
| Watchers | 2,287 |
| 52-Wk Low | $0.06 |
| 52-Wk High | $5.75 |
| Market Cap | $1.61M |
| Volume (M) | 130,301.00 |
| 52-Wk High | $5.75 |
| 52-Wk Low | $0.06 |
Reviewing ICU Medical (NASDAQ:ICUI) and Endologix (OTCMKTS:ELGXQ)Zolmax • over 2 years ago
---
- ICU Medical (NASDAQ:ICUI) and Endologix (OTCMKTS:ELGXQ) are both medical companies,
but which is the better business? We will compare the two companies based on the
strength of their analyst recommendations, institutional ownership, profitability,
valuation, risk, dividends and earnings. ...
Share to Feed
---
- Endologix (OTCMKTS:ELGXQ) and Avinger (NASDAQ:AVGR) are both small-cap medical companies,
but which is the superior stock? We will compare the two businesses based on the
strength of their valuation, institutional ownership, profitability, analyst recommendations,
earnings, dividends and risk. ...
---
- Endologix (OTCMKTS:ELGXQ) and Biostage (OTCMKTS:BSTG) are both small-cap medical
companies, but which is the better business? We will contrast the two companies
based on the strength of their profitability, dividends, analyst recommendations,
institutional ownership, valuation, risk and earnings. ...
---
- Endologix (OTCMKTS:ELGXQ) and Nemaura Medical (NASDAQ:NMRD) are both small-cap medical
companies, but which is the better investment? We will contrast the two businesses
based on the strength of their risk, analyst recommendations, valuation, institutional
ownership, profitability, earnings and ...
---
- Endologix (OTCMKTS:ELGXQ) and Arch Therapeutics (OTCMKTS:ARTH) are both small-cap
medical companies, but which is the superior stock? We will compare the two businesses
based on the strength of their institutional ownership, risk, earnings, dividends,
valuation, profitability and analyst ...
---
- Endologix (OTCMKTS:ELGXQ) was downgraded by Zacks Investment Research from a hold
rating to a sell rating in a note issued to investors on Monday, Zacks.com reports.
According to Zacks, Endologix, Inc. develops, manufactures and markets products
for the treatment ...
---
- Endologix (OTCMKTS:ELGXQ) was downgraded by Zacks Investment Research from a hold
rating to a sell rating in a note issued to investors on Monday, Zacks.com reports.
According to Zacks, Endologix, Inc. develops, manufactures and markets products
for the treatment ...
---
- Endologix (OTCMKTS:ELGXQ) and NuVasive (NASDAQ:NUVA) are both medical companies,
but which is the superior investment? We will compare the two businesses based on
the strength of their profitability, valuation, risk, earnings, analyst recommendations,
dividends and institutional ownership. Risk & ...
---
- Endologix (OTCMKTS:ELGXQ) was upgraded by Zacks Investment Research from a sell
rating to a hold rating in a report released on Tuesday, Zacks.com reports. According
to Zacks, Endologix, Inc. develops, manufactures and markets products for the treatment
of coronary...
---
- Zacks Investment Research cut shares of Endologix (OTCMKTS:ELGXQ) from a hold rating
to a sell rating in a research note released on Thursday, Zacks.com reports. According
to Zacks, Endologix, Inc. develops, manufactures and markets products for the treatment
of coronary and vascular diseases. A ...
